Your CDMO partner for column-free plasmids, viral vectors, GMP sgRNA & exosomes.
With decades of CMC expertise, CoJourney delivers high-yield, high-purity manufacturing solutions custom-tailored to each therapeutic program — from process development to GMP production, with unmatched speed and cost-efficiency.
Built by CMC experts to de-risk your therapy
Three decades of drug manufacturing expertise, condensed into a single-partner journey from process development to commercial GMP.
Expertise
Quality
Cost efficiency
CMC expertise to accelerate your drug development journey
Custom-tailored to your therapeutic program — from research-grade to commercial GMP supply.
Plasmids
Viral vectors
sgRNA
Exosomes
Analytical services
End-to-end CMC
Revolutionising plasmid production, without chromatography.
A column-free, single-use plasmid platform engineered for high-purity gene therapy applications — with proven FDA and CDE IND approvals.
- High-purity plasmids for gene therapy — >95% supercoiled
- Manufacturing costs up to 60–70% lower than competitors
- Single-use flow path — eliminates cross-contamination risk
- Scalable production from 1L to 30L (GMP)
- Viral vector manufacturing scale up to 500L
- Trusted by 100+ clients — 400+ batches delivered
A streamlined, risk-managed CDMO experience
Designed around quality, speed, flexibility and cost-efficiency — with the transparency your regulatory, commercial and scientific teams expect.
Stage-gated contracts
Expert QC
Continuous improvement
Trusted supply chain
Where CoJourney is heading next
CoJourney funding propels US expansion
CoJourney secured $30 million in financing and announced the expansion of its US production operations.
- Cell 2025London, UKNov 11–12, 2025
- Advanced Therapies USA 2025Philadelphia, PANov 18–19, 2025
- Phacilitate Advanced Therapies WeekSan Diego, CAFeb 9–12, 2026
Ready to discuss your next therapeutic program?
Speak with our scientific team about how the CoJourney platforms can accelerate your CMC timelines.